Connect with us

Technology

Kyruus Health Achieves Record Growth as Searches for Care Surpass 1 Billion

Published

on

Care access leader adds 12M health plan members and 100 new provider organizations to its platform

BOSTON, Feb. 5, 2025 /PRNewswire/ — Kyruus Health delivered record-breaking growth in 2024, solidifying its position as the leading care access platform. The company significantly expanded its network, growing its connected providers—across health plans and providers—by almost 20%. Today, over 500,000 providers across 1,400 hospitals, 550 independent medical groups, and 100 health plan brands rely on Kyruus Health to engage patients and members seeking care across various channels, including search engines, portals, and government websites.

Platform utilization across these stakeholders continued to grow in 2024, as Kyruus Health has enjoyed a compound annual growth rate (CAGR) of 51% in care searches, 21% in appointments booked, and 20% in patient check-in’s since 2022, leading to the exchange of 2.7 petabytes of data each month. This substantial growth in utilization underscores the pivotal role of data management in connecting patients who are searching for the right care.

Profitable since 2023, the company also saw significant growth in key financial metrics in 2024, including revenue, gross margin, EBITDA margin, and cash flow. This strong financial performance will further fuel investment in innovation and expansion of the company’s leading care access platform with Kyruus Health projected to exceed $150 million in ARR in 2025.

“This year has been one of extraordinary growth and expansion for Kyruus Health,” said Graham Gardner, MD, founder and CEO at Kyruus Health. “We’re proud to partner with leading healthcare organizations to identify, develop, and deliver the right data and software solutions to help them care for those they serve. As we look ahead, our commitment is to continue developing and acquiring innovative solutions that strengthen the connections between payers and providers, ensuring that patients receive the access they need through seamless, data-driven engagement.”

Enhancing the Member and Patient Experience Thru Data Management
For health plans, Kyruus Health’s ability to bring together provider data alongside cost data enables accurate and actionable member journeys through digital experiences or API infrastructure. This not only enhances member engagement but also enables compliance with provider directory accuracy regulations and strengthens network adequacy efforts. In delivering seamless digital patient experiences across leading EHRs, Kyruus Health strengthens patient access strategies by allowing health systems to fully leverage their digital investments, bridging gaps to boost patient engagement, drive brand awareness, and increase appointment bookings.

Driving Success Through Innovation
Kyruus Health continued its commitment to delivering exceptional value for clients through continuous product innovation across Kyruus Health’s care access platform. In 2024, the company propelled this innovation even further with the release of three strategic products:

Reach: Amplifying Patient Acquisition – Harnessing the robust provider data capabilities of Kyruus Connect, Reach empowers healthcare organizations to effortlessly manage and update their digital listings. With a focus on channels proven to drive patient traffic and appointments, Reach optimizes online presence for maximum impact. Launched just three months ago, Reach is already transforming patient acquisition. Intermountain Health, an early adopter, saw a 42% increase in appointments booked via Reach’s integration with Google Reserve in the first two months.Guide: Navigating Care with AI-Powered Simplicity – Leveraging the power of large language models, Guide utilizes natural language processing and generative AI to revolutionize the patient care journey. By understanding and responding to natural language queries and leveraging our data management infrastructure, Guide creates a seamless and intuitive experience for individuals seeking the right answers and the right care. Guide helps members select the provider who best fits their medical and personal preferences. It achieves this by offering clear, concise definitions of clinical specialties and medical terminology, empowering patients to make informed decisions.Provider Data Solutions: The Foundation of Accurate, Accessible Care – Kyruus Health’s Provider Data Solutions ensure quality data through comprehensive ingestion, curation, and cleansing of provider information from diverse sources. Building on existing compliance and attestation capabilities, these solutions create a single, trusted source of truth for provider data. This ensures convenience, reliability, and accuracy across all access points. Kyruus Health’s payer customers are already experiencing the benefits, with enhanced provider profiles leading to increases in member interactions of up to 114%.

Looking Ahead to 2025
“Kyruus Health is well-positioned to capitalize on the growing demand for solutions that improve care access and navigation,” noted Paul Merrild, President at Kyruus Health. “The company’s strong revenue growth, expanding market reach, and commitment to innovation have helped make it the go-to platform for organizations looking to optimize how to engage patients and guide them to the right care. As the healthcare industry continues to evolve, Kyruus Health’s focus on connecting patients with the right care through a data-driven approach is essential to growth and engagement.”

ABOUT KYRUUS HEALTH
Kyruus Health is the leading care access platform on a mission to connect people to the right care. The company connects over 500,000 providers across 1,400 hospitals and 550 medical groups, and members across 100 health plan brands, so every stakeholder can access and harness the most accurate, comprehensive, and contextually relevant information. By enabling informed decisions and confident action, the care access platform supports healthier outcomes, reduces friction in healthcare, and grants more time back in everyone’s day. To learn more, visit KyruusHealth.com or follow us on LinkedIn.

MEDIA CONTACTS
Jeff Rusack
Media Relations Manager, KNB Communications
kyruushealth@knbcomm.com

Ashley Dauwer
Corporate Marketing and PR Manager, Kyruus Health
adauwer@kyruushealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/kyruus-health-achieves-record-growth-as-searches-for-care-surpass-1-billion-302368755.html

SOURCE Kyruus Health

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Progressive Planet Reports Q3 Results: $422K EBITDA vs. $732K Last Year and $4.8M Cash on Hand as of January 31, 2025

Published

on

By

/NOT FOR DISTRIBUTION IN THE USA/

–  Progressive Planet reports highest cash on hand ever
–  Receives $1.56 million of grant funding for pilot plant
–  Gross margin impacted by several one-time expenses and events

KAMLOOPS, BC, March 13, 2025 /CNW/ – Progressive Planet Solutions Inc. (TSXV: PLAN) (OTCQB: ASHXF) (“Progressive Planet”, “PLAN”, or the “Company”) is pleased to announce its financial results for its third quarter ending on January 31, 2025.

The Company was profitable in the current quarter and continued to grow to its cash position from operational cash flow as well as from the receipt of grant funding. Gross margin was lower due to some higher costs along with taking a write down on a receivable from the bankruptcy of a Canadian chain of stores.

Key Financial Results – Q3 Fiscal 2024 vs. Q3 Fiscal 2025:

The Company’s cash balance increased by $1,867,662 during the current quarter, ending at $4,819,839 on January 31, 2025. This included $1,555,682 in grant funding received.Revenue decreased by 1% to $4,779,099 compared to $4,812,604 in Q3 F2024 (the comparable period in the prior fiscal year).Planned plant shutdown in quarter impacted production and revenues.Gross profit decreased 13% to $1,359,051 compared to $1,566,847 in Q3 F2024.Income from operations was $231,455 compared to $549,255 in Q3 F2024.Net income was $114,838 compared to $348,689 in Q3 F2024.Existing credit facilities remain unused with greater than $3,000,000 in credit available at January 31, 2025.

“While we remain profitable and continue to grow our cash on hand, Q3 had its challenges including the write down of a receivable associated with a rural chain of farm supply stores which went bankrupt. We also went though a scheduled shutdown in the quarter where we lost one week of production. We saw increases in operating costs in several areas including freight,” said Harpur. “While we commenced investment in robotics in the quarter, we will not see savings on variable production costs until Q3 of next year, when our new robotic investments will be installed and operational,” continued Harpur.

EBITDA is a non-IFRS financial measure. This ratio expresses earnings before interest, income taxes, depreciation, and amortization. It assists in explaining the Company’s results from period to period. There is not directly comparable IFRS measure.Gross margin is a non-IFRS financial measure. This ratio expresses gross profit as a percentage of revenue for a given period. It assists in explaining the Company’s results from period to period and measuring profitability. This ratio is calculated by dividing gross profit for a period by the corresponding revenue for the period. There is no directly comparable IFRS measure.

_________________________

Progressive Planet provides regular information for investors on its website:  progressiveplanet.com/investors/. This includes press releases and other information about financial performance, patents filed, and information on corporate governance. For further information or investor relations inquiries, please contact:

Steve Harpur, CEO
1 (800) 910-3072
investors@progressiveplanet.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

About Progressive Planet:

Progressive Planet, based in Kamloops, British Columbia, is redefining sustainability with our Products for a Healthy Planet™. By leveraging owned mineral assets and recycled materials, we develop patented and patent-pending innovations that promote a healthier planet.

Our C-Quester™ Centre of Sustainable Solutions leads advancements in low-carbon cement technologies, while our second on-site lab focuses on sustainable solutions for agriculture and animal care. Progressive Planet’s products are proudly available in over 10,000 retail locations across North America. For more information, visit progressiveplanet.com.

Forward-Looking Statements:
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the matters described herein. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance, or developments to differ materially from those contained in the statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management’s current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including factors beyond the Company’s control. These forward-looking statements are made as of the date of this news release.

Disclaimer:
This news release, required by Canadian laws, does not constitute an offer of securities and is not for distribution or dissemination outside Canada.

SOURCE Progressive Planet Solutions Inc.

Continue Reading

Technology

Argos Multilingual Publishes the “End-User in the Loop: Why the How of Using GenAI Matters” Report

Published

on

By

Argos Multilingual, a global content solutions leader, launches its newest flagship research publication, the “End-User in the Loop: Why the How of Using GenAI Matters” report. The report is based on an end-user survey gathering perspectives on AI from respondents across eight countries: Brazil, China, France, Germany, India, Japan, Spain, and the United States. It explores key questions of transparency, trust, and bias.

SAN FRANCISCO, March 13, 2025 /PRNewswire-PRWeb/ — Argos Multilingual, a global content solutions leader, launches its newest flagship research publication, the “End-User in the Loop: Why the How of Using GenAI Matters” report. The report is based on an end-user survey gathering perspectives on AI from respondents across eight countries: Brazil, China, France, Germany, India, Japan, Spain, and the United States. It explores key questions of transparency, trust, and bias.

In a world dominated by headlines about GenAI’s capabilities, this publication highlights a critical factor in any AI initiative: its success depends on helping end-users achieve their goals.

In a world dominated by headlines about GenAI’s capabilities, this publication highlights a critical factor in any AI initiative: its success depends on helping end-users achieve their goals. Any enterprise that produces, markets, or distributes AI-generated content ultimately relies on keeping the end-user in the loop.

The “End-User in the Loop” report is the latest result of Argos’ efforts to offer world-class, technology-centric advisory to its clients. It aligns with the company’s belief that humans are central to maximizing AI’s transformative potential, whether in creating engaging content or developing innovative product features.

Download the full End-User in the Loop: Why the How of Using GenAI Matters and Why We Look to the End-User to Keep Us All Honest report here.

Highlights from the report

AI hype has had its benefits — awareness and exposure to generative AI continue to grow across the board. Users have now encountered it enough to form critical opinions and expectations about how brands should implement the technology.

77% of users have previously mistaken AI-generated content for human content: Mistakes happen, and there is a learning curve when engaging with AI. However, this underscores the importance of transparency so that users are never at a disadvantage when interacting with AI-powered systems or consuming AI-generated content.

78% of respondents say they have had to fact-check GenAI output: This demonstrates a potential obstacle to making GenAI widely accessible and usable. When user experience is the priority, it shouldn’t be the user’s responsibility to do extra work to get reliable results.

Users focus on achieving their goals: 71% of respondents say they don’t mind the occasional language error when interacting with AI, as long as it helps them accomplish their objectives. For brands, success depends on understanding user intent.

Human preference leans toward human-created content: 81% of users prefer content produced by humans. Creativity, originality, and human flair in content or brand messaging remain irreplaceable — for now.

About Argos Multilingual

Argos Multilingual provides global language solutions. With over 30 years of experience, we serve clients in the high-tech, life sciences, human resources, and financial industries. We make it easy for businesses to grow globally and connect with expert talent anywhere in the world. With production centers in Europe, the Americas, and Asia, we follow a strategy of building robust programs for continuous translation and localization. You can expect a long-term and transparent partnership, backed by innovative solutions around technology, AI & data, creative content, and quality assurance. For more information, please visit us at www.argosmultilingual.com.

Media Contact

Stephanie Harris-Yee, Argos Multilingual, 1 415 738-7705, info@argosmultilingual.com, https://www.argosmultilingual.com/

LinkedIn

View original content:https://www.prweb.com/releases/argos-multilingual-publishes-the-end-user-in-the-loop-why-the-how-of-using-genai-matters-report-302399483.html

SOURCE Argos Multilingual

Continue Reading

Technology

Pivot Bio Unveils PROVEN G3, with Powerful New Modes of Action and Patent-Protected Gene-Editing Technology

Published

on

By

Company Continues to Lead the Biologicals Industry with Third-Generation Nitrogen Product Line

Product to Be Available to Growers in the United States

ST. LOUIS, March 13, 2025 /PRNewswire/ — Pivot Bio, one of the world’s leading innovative agtech companies, announced that it has launched a new product in its line of innovative ag solutions for growers in the U.S. Pivot Bio PROVEN® G3 will join the company’s notable Pivot Bio PROVEN® 40 nitrogen-fixing solution, which has been successfully used by growers on millions of acres to date. PROVEN G3, the company’s third-generation nitrogen solution for corn, will be commercially available in 2026, pending state registrations. This marks a major advancement in nitrogen innovation, as PROVEN G3 is the first PROVEN product with multiple modes of action and significant benefits to American farmers, who work hard to feed, clothe and fuel the world.

“Built to enhance our industry-leading and proprietary gene-edited nitrogen-fixing technology, PROVEN G3 adds an exclusive microbe blend that increases nutrient uptake and nitrogen-use efficiency. PROVEN G3 consistently drives improved nitrogen production, seamlessly enhancing farmers’ current nitrogen programs and yield potential,” said Ryan Van Roekel, Ph.D., commercial agronomy leader for Pivot Bio.

“Pivot Bio realizes every farm presents unique challenges, including varying soil types, field conditions and nutrient-management approaches,” said Van Roekel. “PROVEN G3 was designed by some of the top scientists and agronomists working side by side with growers to adapt to these differences, allowing farmers to customize timing and placement to maximize efficiency, productivity and profitability across their diverse acres. As a weatherproof and most efficient source of nitrogen per pound, PROVEN G3 seamlessly integrates into current fertility programs.”

With PROVEN G3, the company will continue its industry-leading research program with notable colleges and universities and will be completing the largest farmer demo in Pivot Bio’s history, spanning 300-plus locations, demonstrating the performance and consistency of PROVEN G3 at scale.

This research will join recent peer-reviewed research from Wisconsin and Purdue universities, published in Scientific Reports, confirming that Pivot Bio’s gene-edited microbes successfully fix nitrogen from the air and deliver it directly to plant roots, even in the presence of synthetic fertilizers. Additionally, a three-year study from the University of Illinois further validates Pivot Bio’s products as a reliable third source of nitrogen for corn. The research demonstrates that crops utilizing Pivot Bio’s gene-edited technology absorb more nitrogen —including nitrogen derived from the atmosphere — helping farmers implement multi-mode nitrogen plans for improved efficiency and productivity.

In addition to this latest advancement for corn, the company also recently announced a new product launch for cotton — a first for the cotton market — with CERT-N™.

About the Technology: 
Not all nitrogen-fixing microbes perform the same. Traditional or “native,” non-gene-edited microbes stop fixing nitrogen when other nitrogen sources are present, limiting their effectiveness in real-world field conditions. Pivot Bio’s proprietary gene-edited technology sets a new standard. As the only company with patented gene-edited nitrogen-fixing microbes, Pivot Bio ensures its microbes continue working during key growth stages, even in the presence of synthetic or organic fertilizers.

With a growing number of biological products entering the market, Pivot Bio’s product portfolio stands apart, built on a foundation of exclusive, patent-protected innovation that no other company can replicate. Backed by rigorous research and real-world testing, this technology helps farmers protect against nitrogen loss, sustain top-end yield potential and improve efficiency, seamlessly integrating into existing fertility plans.

About PROVEN G3: PROVEN G3 is powered by Pivot Bio’s patented gene-edited technology and introduces a new proprietary microbe blend, working through three distinct modes of action to enhance nitrogen fixation, and optimize nutrient uptake and nitrogen use efficiency.

1.  Boosting crop growth by increasing the uptake of critical nutrients.

Helps mobilize additional nutrients, such as iron and manganese, maximizing plant uptake.

2.  Feeding nitrogen directly to the roots daily via the only patented gene-edited nitrogen-fixing microbe that continues to supply nitrogen even when other nitrogen is present.

3.  Amplifying yield potential via greater plant health and driving enhanced nitrogen-use efficiency.

Supports biomass growth and overall plant health, ultimately driving greater yield potential.

This next-generation innovation reinforces Pivot Bio’s commitment to delivering more predictable and efficient nitrogen solutions that work seamlessly alongside farmers’ existing practices.

About Pivot Bio
Pivot Bio, one of the world’s leading innovative agtech companies, delivers to farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow the food the world needs in the face of increasing volatility. Currently available in North America and soon in Brazil, the company’s products are a breakthrough innovation and one of the agriculture industry’s most promising solutions. Pivot Bio has been recognized three times by Time magazine on its annual list of best inventions, by Fast Company on its World Changing Ideas and World’s 50 Most Innovative Companies lists, by CNBC on its Disruptor 50 list of private companies, by Fortune on its Impact 20 list of startups driving social good and by MIT Tech Review as one of 15 climate tech companies to watch. For more information, visit PivotBio.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pivot-bio-unveils-proven-g3-with-powerful-new-modes-of-action-and-patent-protected-gene-editing-technology-302401522.html

SOURCE Pivot Bio, Inc

Continue Reading

Trending